Literature DB >> 15378653

K+ channel blockade impairs remyelination in the cuprizone model.

Andrzej Bacia1, Robert Wollmann, Betty Soliven.   

Abstract

The adult CNS has the capacity to remyelinate following metabolic, toxic and autoimmune demyelinating insults. In cuprizone-induced demyelination, spontaneous remyelination occurs after the cessation of cuprizone diet. We used the cuprizone model to investigate the role of glial K(+) channels in oligodendroglial (OLG) regeneration and remyelination in vivo. We found that treatment with 4-aminopyridine (4-AP), a broad-spectrum K(+) channel antagonist, results in: (1) decreased number of oligodendroglial progenitors (OP) and OLGs; (2) diminished astrogliosis; and (3) decreased remyelination in the corpus callosum based on the immunoreactivity to myelin basic protein (MBP), Rip monoclonal antibody, and by electron microscopy. Our findings support the concept that glial K(+) channels play an important role during OLG regeneration and remyelination, a crucial factor to be considered during the development of therapeutic strategies to facilitate recovery in demyelinating diseases and spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378653     DOI: 10.1002/glia.20067

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

1.  CNS Schwann cells display oligodendrocyte precursor-like potassium channel activation and antigenic expression in vitro.

Authors:  Kristel Kegler; Ilka Imbschweiler; Reiner Ulrich; Peter Kovermann; Christoph Fahlke; Ulrich Deschl; Arno Kalkuhl; Wolfgang Baumgärnter; Konstantin Wewetzer
Journal:  J Neural Transm (Vienna)       Date:  2014-02-01       Impact factor: 3.575

2.  C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Monika Rozycka; Katerina Soloviova; Takahiro Ito; Anil K Singh; Aamer Khan; Philippe Azimzadeh; Maria Andrian-Albescu; Anver Khan; Florin Niculescu; Violeta Rus; Susan I V Judge; Horea Rus
Journal:  Exp Mol Pathol       Date:  2011-04-22       Impact factor: 3.362

3.  Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.

Authors:  Hye Jung Kim; Veronique E Miron; Danuta Dukala; Richard L Proia; Samuel K Ludwin; Maria Traka; Jack P Antel; Betty Soliven
Journal:  FASEB J       Date:  2011-01-19       Impact factor: 5.191

Review 4.  Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond.

Authors:  Verena Isabell Leussink; Xavier Montalban; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

5.  K(V)7/KCNQ channels are functionally expressed in oligodendrocyte progenitor cells.

Authors:  Wei Wang; Xiao-Fei Gao; Lin Xiao; Zheng-Hua Xiang; Cheng He
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

Review 6.  Microenvironment Imbalance of Spinal Cord Injury.

Authors:  Baoyou Fan; Zhijian Wei; Xue Yao; Guidong Shi; Xin Cheng; Xianhu Zhou; Hengxing Zhou; Guangzhi Ning; Xiaohong Kong; Shiqing Feng
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

7.  Neuroprotective effect of newly synthesized 4-aminopyridine derivatives on cuprizone-induced demyelination in mice-a behavioral and immunohistochemical study.

Authors:  Ivanka Kostadinova; Boycho Landzhov; Lyubomir Marinov; Lyubomir Vezenkov; Nikolai Danchev
Journal:  Amino Acids       Date:  2021-07-08       Impact factor: 3.520

Review 8.  Myelin damage and repair in pathologic CNS: challenges and prospects.

Authors:  Arsalan Alizadeh; Scott M Dyck; Soheila Karimi-Abdolrezaee
Journal:  Front Mol Neurosci       Date:  2015-07-27       Impact factor: 5.639

9.  Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination.

Authors:  Bandita Bagchi; Ahmed Al-Sabi; Seshu Kaza; Dimitri Scholz; Valerie B O'Leary; J Oliver Dolly; Saak V Ovsepian
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.